Biocartesian converts biology into digital molecular maps. We build tools for spatial biology, functional genomics, and high-content screening. Our ARADIA™ technology enables DNA sequences to be read directly from within cells, allowing researchers to run pooled screens of CRISPR guides, CAR constructs, and other genetic perturbations using microscopy. We work with pharmaceutical, biotechnology, and academic teams on target discovery, biomarkers, mechanism-of-action studies, CRISPR screening, cell therapy engineering, and complex cellular phenotyping. Biocartesian is headquartered in Philadelphia, PA. For more information, please visit www.biocartesian.com.
| Website | https://www.biocartesian.com |
| Employees | 3 (1 on RocketReach) |
| Address | 3675 Market St, Philadelphia, Pennsylvania 19104, US |
| Industry | Biotechnology Research |
| Keywords | Biopharma, Biotechnology, Drug Development, Drug Discovery, Bioprocessing, Pharmaceutical Research, Medical Technology, Biologics, Immunotherapy, Life Sciences, Therapeutic Antibodies, Protein Engineering, Cell Therapy, Precision Medicine, Molecular Diagnostics, Pharmaceutical Manufacturing, Gene Editing, Regenerative Medicine, Cell Engineering, Clinical Trials |
Looking for a particular Biocartesian employee's phone or email?
Biocartesian Questions
Ian Dardani is the Co-founder and CEO of Biocartesian.
1 people are employed at Biocartesian.
Biocartesian is based in Philadelphia, Pennsylvania.
Top Biocartesian Employees
-
Ian Dardani
Co-founder and CEO at Biocartesian
Philadelphia, PA, US14
